{"ticker": {"uuid": "c28ab7d4-d7c3-411b-9d99-17587fd08379", "symbol": "THAT", "name": "Thalia Therapeutics Plc", "exchange": "LSE", "country": "GB", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "UK BioTech Thalia Therapeutics raises \u20ac3.1 million and acquires Sanmirna Therapeutics", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxPNktFaGlueG9yMlBFVm5uNTM2SHp2QWdweGtQUW9ScmZIMXkwMVBIUmxNRjV4a3BNcmo5M3ZCVU5Hd1VONm00V3ptOTlOVGJ4X1VlRUZMWTVmQXpqOWJoYjBuYlpITXpXY2M2bUVXVmFXQzJGWlRCcGJlMTVTa0pjMWxhSE1YamxYLVNLVGhuS0lFMjQyaGFkNHZDQmhtNURaQlNRejQza0FIX1Z6VFBPMnpkaGdjZw?oc=5", "source_name": "BeBeez International", "published_at": "2026-06-26T07:00:00+00:00", "published_display": "26 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Thalia shares jump 20% on AML drug acquisition and \u00a32.75m raise", "summary": "", "url": "https://news.google.com/rss/articles/CBMizwFBVV95cUxOOFFrTnRuaFJ6a19sQVluSk1TOWVGaTVXNFFEajZoNWxRTkRObGs3RGpHSXlPZWVDck9qRHViR1BPWUFvTmZvTTA4YlZTZlZPckpqREtnME05RXZaSnM2QWtwVHBET3VWc3VpRmExaDJwNjN2d3VleV94dVZhTlhtdGRLREo4VnRmNUkyMWpSRF9sWUVnVFZhdUluYWt1TGJ0OXZEeHBkMHVtWEVDcVpRblRibTJ1OXhMZGU5MFNSZW9LdjJBRTgzbHZ4clZYV3c?oc=5", "source_name": "Proactive Investors", "published_at": "2026-06-24T07:00:00+00:00", "published_display": "24 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AIM Market Roundup: Thalia Therapeutics, Novacyt, TMT Investments", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAFBVV95cUxNUzk4RG8zTUZuaWxxRkNEWDAtVWhpajk1M2lMbF94SmxaVDkwVjAzXy1TaUpELWx6SjVzN09TSFRvbkZUUzR0TmhPOGFxTHJNU0l6a0x3X1JOdGxDQ0hOV3YycW9uZEZLaWxCSGFod1dHbkFIcnY3MTJWTEdLd01XNkkwS21Pa3JScWdLSGhlVWc?oc=5", "source_name": "Market source", "published_at": "2026-06-24T07:00:00+00:00", "published_display": "24 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "REG - Thalia Therapeutics - Acquisition and \u00a32.75 million Fundraise", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1AFBVV95cUxNdlctanJxSFE3dkJIYVMyQW9WR1Q5MVpGNEFGMC1mNlVWUnRJTzJ2RVZVOXhOZ0JaYVgxWFY2X0JrOWo4Y2V3dGxxV2YxckZFbGNKWnpRTzJSV2VtTm1ucE5wVF85YXBva2gta0hVdHcwaGF5WTZPYjI1NjFleTFhX0xIVjJUek5kZmRhdEU2QTFqZU5vWFdzVUhaaU5XcFN3OVFhZVJjMlZsNThJOWI0VGR3ckFnVThURHR3RHhYR0VhcldFaGVmUU5kVkVUcTVTT1A4Wg?oc=5", "source_name": "TradingView", "published_at": "2026-06-23T07:00:00+00:00", "published_display": "23 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Thalia Therapeutics plc Share Price - THAT, RNS News, Articles, Quotes, & Charts (LON:N4P)", "summary": "", "url": "https://news.google.com/rss/articles/CBMidkFVX3lxTE8yX2hnWlp1RmNVemRDbWowTl9JRzhMYTJwbzhfQkU5LWlqcXhqNFhfMU81UHhNN01RRjB3aVJPR01BOGNuNThSb3BIMEFGOU12TGdMSnlpczBpS1d3ODBjRmVjYXBXNmpsbVVobmozQk85MnBJSlE?oc=5", "source_name": "Proactive financial news", "published_at": "2026-06-05T10:34:06+00:00", "published_display": "05 Jun 2026 10:34", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Thalia Therapeutics ord 0.4p share price | THAT", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxOTWc1cVlvcC0wOElLMnZPVW1NOTlFYi1fSGdJa0Fyemg3U0ZSRHJrLWZlYzlhZDR0aVBDaGJteXlkY0tGMUpZM2YyY2Q1bUlfM0tpLU9wRVNPWDZsRnZUMC1IYzdJVVM5STRTVDEzQkFsa2VMb2t1SVZpQ3U0QlBhTFUzclJ0cTA?oc=5", "source_name": "Hargreaves Lansdown", "published_at": "2026-03-18T16:37:19+00:00", "published_display": "18 Mar 2026 16:37", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "THAT Stock Price and Chart \u2014 LSE:THAT", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWEFVX3lxTE1mLUFHQ0RlYlRqV1FLdDBNdjlzdXZkTUtIdVFhZnVSX1JrdWU4clY5TjFnQzdUcnFEbWRJZGx4MjBBRGEwelVsbUpRdjhaWFhVeUozc0lJckE?oc=5", "source_name": "TradingView", "published_at": "2026-03-18T09:51:03+00:00", "published_display": "18 Mar 2026 09:51", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Sainsbury's quietly becoming the UK's best supermarket... and does the stock reflect that?", "summary": "", "url": "https://news.google.com/rss/articles/CBMi9AFBVV95cUxOeVVBWFhqTnVxSlA3TnZRbmxvSzY1R0daTEZXcVpXNklzdFlyaDZuQVB2b3ZuV1dVU1JsRXExYVNRUjJENHFsWDd5bkI0UkVrZGxUUmxxakh1dnhvdHEtSTczbTJuTzFQTFRaendQR2lvMk5JSW5obFFkN0wzM3hUQ3k1SkhCQ28wc2tBaXQwWlhvSkttSmdTNXlDR2JyNTVzZVBYalRmcEdEalZTRjhhSnMzOTBfdmlLR1d1aG9QLUVjejdQSmZUZHJkRVo3QTV1NEVvYmhGbmVMaS1HY0hMRHpjN0VwZ183WWFndUJUMXRQQUsx?oc=5", "source_name": "Proactive Investors", "published_at": "2026-03-11T07:00:00+00:00", "published_display": "11 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Thalia Therapeutics", "summary": "", "url": "https://news.google.com/rss/articles/CBMic0FVX3lxTFBfRldjRERyaFdvVnN2eDg1d1VOUTVTbktJejFIWlFaNzdUcmZKeEc0aXk3OGFMUFd1TGZBbU1TRHFhV1Ffc290RUFiVWRYLUVUZTlfZEdXbW0yQzJoa1ZnYWJ4aktlRmVkeGRpWnRkZzFQeFE?oc=5", "source_name": "The Pharma Letter", "published_at": "2026-02-26T21:48:12+00:00", "published_display": "26 Feb 2026 21:48", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "UK BioTech Thalia Therapeutics raises \u20ac3.1 million and acquires Sanmirna Therapeutics", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxPNktFaGlueG9yMlBFVm5uNTM2SHp2QWdweGtQUW9ScmZIMXkwMVBIUmxNRjV4a3BNcmo5M3ZCVU5Hd1VONm00V3ptOTlOVGJ4X1VlRUZMWTVmQXpqOWJoYjBuYlpITXpXY2M2bUVXVmFXQzJGWlRCcGJlMTVTa0pjMWxhSE1YamxYLVNLVGhuS0lFMjQyaGFkNHZDQmhtNURaQlNRejQza0FIX1Z6VFBPMnpkaGdjZw?oc=5", "source_name": "BeBeez International", "published_at": "2026-06-26T07:00:00+00:00", "published_display": "26 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Thalia shares jump 20% on AML drug acquisition and \u00a32.75m raise", "summary": "", "url": "https://news.google.com/rss/articles/CBMizwFBVV95cUxOOFFrTnRuaFJ6a19sQVluSk1TOWVGaTVXNFFEajZoNWxRTkRObGs3RGpHSXlPZWVDck9qRHViR1BPWUFvTmZvTTA4YlZTZlZPckpqREtnME05RXZaSnM2QWtwVHBET3VWc3VpRmExaDJwNjN2d3VleV94dVZhTlhtdGRLREo4VnRmNUkyMWpSRF9sWUVnVFZhdUluYWt1TGJ0OXZEeHBkMHVtWEVDcVpRblRibTJ1OXhMZGU5MFNSZW9LdjJBRTgzbHZ4clZYV3c?oc=5", "source_name": "Proactive Investors", "published_at": "2026-06-24T07:00:00+00:00", "published_display": "24 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AIM Market Roundup: Thalia Therapeutics, Novacyt, TMT Investments", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAFBVV95cUxNUzk4RG8zTUZuaWxxRkNEWDAtVWhpajk1M2lMbF94SmxaVDkwVjAzXy1TaUpELWx6SjVzN09TSFRvbkZUUzR0TmhPOGFxTHJNU0l6a0x3X1JOdGxDQ0hOV3YycW9uZEZLaWxCSGFod1dHbkFIcnY3MTJWTEdLd01XNkkwS21Pa3JScWdLSGhlVWc?oc=5", "source_name": "Market source", "published_at": "2026-06-24T07:00:00+00:00", "published_display": "24 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "REG - Thalia Therapeutics - Acquisition and \u00a32.75 million Fundraise", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1AFBVV95cUxNdlctanJxSFE3dkJIYVMyQW9WR1Q5MVpGNEFGMC1mNlVWUnRJTzJ2RVZVOXhOZ0JaYVgxWFY2X0JrOWo4Y2V3dGxxV2YxckZFbGNKWnpRTzJSV2VtTm1ucE5wVF85YXBva2gta0hVdHcwaGF5WTZPYjI1NjFleTFhX0xIVjJUek5kZmRhdEU2QTFqZU5vWFdzVUhaaU5XcFN3OVFhZVJjMlZsNThJOWI0VGR3ckFnVThURHR3RHhYR0VhcldFaGVmUU5kVkVUcTVTT1A4Wg?oc=5", "source_name": "TradingView", "published_at": "2026-06-23T07:00:00+00:00", "published_display": "23 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Thalia Therapeutics plc Share Price - THAT, RNS News, Articles, Quotes, & Charts (LON:N4P)", "summary": "", "url": "https://news.google.com/rss/articles/CBMidkFVX3lxTE8yX2hnWlp1RmNVemRDbWowTl9JRzhMYTJwbzhfQkU5LWlqcXhqNFhfMU81UHhNN01RRjB3aVJPR01BOGNuNThSb3BIMEFGOU12TGdMSnlpczBpS1d3ODBjRmVjYXBXNmpsbVVobmozQk85MnBJSlE?oc=5", "source_name": "Proactive financial news", "published_at": "2026-06-05T10:34:06+00:00", "published_display": "05 Jun 2026 10:34", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Thalia Therapeutics ord 0.4p share price | THAT", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxOTWc1cVlvcC0wOElLMnZPVW1NOTlFYi1fSGdJa0Fyemg3U0ZSRHJrLWZlYzlhZDR0aVBDaGJteXlkY0tGMUpZM2YyY2Q1bUlfM0tpLU9wRVNPWDZsRnZUMC1IYzdJVVM5STRTVDEzQkFsa2VMb2t1SVZpQ3U0QlBhTFUzclJ0cTA?oc=5", "source_name": "Hargreaves Lansdown", "published_at": "2026-03-18T16:37:19+00:00", "published_display": "18 Mar 2026 16:37", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "THAT Stock Price and Chart \u2014 LSE:THAT", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWEFVX3lxTE1mLUFHQ0RlYlRqV1FLdDBNdjlzdXZkTUtIdVFhZnVSX1JrdWU4clY5TjFnQzdUcnFEbWRJZGx4MjBBRGEwelVsbUpRdjhaWFhVeUozc0lJckE?oc=5", "source_name": "TradingView", "published_at": "2026-03-18T09:51:03+00:00", "published_display": "18 Mar 2026 09:51", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Sainsbury's quietly becoming the UK's best supermarket... and does the stock reflect that?", "summary": "", "url": "https://news.google.com/rss/articles/CBMi9AFBVV95cUxOeVVBWFhqTnVxSlA3TnZRbmxvSzY1R0daTEZXcVpXNklzdFlyaDZuQVB2b3ZuV1dVU1JsRXExYVNRUjJENHFsWDd5bkI0UkVrZGxUUmxxakh1dnhvdHEtSTczbTJuTzFQTFRaendQR2lvMk5JSW5obFFkN0wzM3hUQ3k1SkhCQ28wc2tBaXQwWlhvSkttSmdTNXlDR2JyNTVzZVBYalRmcEdEalZTRjhhSnMzOTBfdmlLR1d1aG9QLUVjejdQSmZUZHJkRVo3QTV1NEVvYmhGbmVMaS1HY0hMRHpjN0VwZ183WWFndUJUMXRQQUsx?oc=5", "source_name": "Proactive Investors", "published_at": "2026-03-11T07:00:00+00:00", "published_display": "11 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Thalia Therapeutics", "summary": "", "url": "https://news.google.com/rss/articles/CBMic0FVX3lxTFBfRldjRERyaFdvVnN2eDg1d1VOUTVTbktJejFIWlFaNzdUcmZKeEc0aXk3OGFMUFd1TGZBbU1TRHFhV1Ffc290RUFiVWRYLUVUZTlfZEdXbW0yQzJoa1ZnYWJ4aktlRmVkeGRpWnRkZzFQeFE?oc=5", "source_name": "The Pharma Letter", "published_at": "2026-02-26T21:48:12+00:00", "published_display": "26 Feb 2026 21:48", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 90, "total_relevant": 9, "sentiment_summary": {"positive": 2, "negative": 0, "neutral": 7, "score": 54, "total": 9, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 85, "events": [{"event": "general", "label": "Market update", "weight": 3.85, "count": 7}, {"event": "deals", "label": "Deals and strategy", "weight": 1.1, "count": 2}], "positive_events": 2, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 0.01, "latest_week": "2026-07-10", "one_week_move": 0.0, "four_week_move": 13.0, "twelve_week_move": 13.0, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 0.894512, "market_dynamics_buy_signal": false, "relative_strength": 13.258117, "fair_value_gap": -1.9, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "negative", "expectation_probability": 22.1768, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "+0.0% over one week, +13.0% over four weeks, trend active, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 55, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Proactive Investors", "count": 2}, {"label": "TradingView", "count": 2}, {"label": "BeBeez International", "count": 1}, {"label": "Market source", "count": 1}, {"label": "Proactive financial news", "count": 1}, {"label": "Hargreaves Lansdown", "count": 1}, {"label": "The Pharma Letter", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 9}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 7}, {"label": "Deals and strategy", "count": 2}]}, "insights": [{"label": "Weighted tone", "value": "54/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "85/100 classification confidence."}, {"label": "Company focus", "value": "9", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "+0.0% over one week, +13.0% over four weeks, trend active, and near fair-value range."}, {"label": "Latest direct headline", "value": "Positive", "tone": "positive", "text": "UK BioTech Thalia Therapeutics raises \u20ac3.1 million and acquires Sanmirna Therapeutics"}], "updated_at": "2026-07-16T17:59:37.279295+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}